Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 1 Business Day
Clinical Trials Supply & Logistics Market Growth & Trends
The global clinical trials supply & logistics market is expected to reach USD 6.3 billion by 2030, expanding at a CAGR of 7.5% from 2023 to 2030. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.
Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.
There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.
Clinical Trials Supply & Logistics Market Report Highlights
Clinical Trials Supply & Logistics Market Growth & Trends
The global clinical trials supply & logistics market is expected to reach USD 6.3 billion by 2030, expanding at a CAGR of 7.5% from 2023 to 2030. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.
Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.
There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.
Clinical Trials Supply & Logistics Market Report Highlights
- In service segment, logistics & distribution dominated the market in 2022 with a share of 25.3%. This is due to the rise in clinical trials due to COVID- 19 pandemic
- Based on phase, phase III segment dominated the market with a market share of 43.4% in 2022
- Based on therapeutic area, cardiovascular diseases accounted for the fastest CAGR of 8.0% during the forecast period. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
- Asia Pacific is anticipated to register the fastest growth rate of 8.1% during the forecast period. This is due to low recruitment cost, region has access to a large and diversified patient pool, and favorable policies that make the region desirable for clinical trials
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Phase
1.1.3 End-User
1.1.4 Therapeutic Use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
CHAPTER 3 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Technological advancements in supply chain
3.1.1.2 Increasing R&D investment by pharmaceutical and biopharmaceutical firms
3.1.1.3 Expansion of clinical trial sites
3.1.2 Market Restraint Analysis
3.1.2.1 Stringent regulation pertaining to logistics
3.1.2.2 Counterfeiting of drugs
3.1.3 SWOT Analysis by PESTEL
3.1.4 Industry Analysis - Porter’s
3.1.5 Clinical Trial Supply & Logistics Market: Impact of COVID -
3.1.5.1 IMPACT OF COVID -
3.1.5.2 SUPPLY CHAIN
3.1.5.3 CHANGING MARKET TRENDS
CHAPTER 4 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY SERVICE, 2018 - 2030 (USD MILLION)
4.1 Definitions and Scope
4.2 Clinical Trial Supply & Logistics Market by Service: Segment Dashboard
4.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
4.3.1 logistics & Distribution
4.3.1.1 Logistics & Distribution Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.2 Storage & Retention
4.3.2.1 Storage & Retention Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.3 Packaging, Labeling, And Blinding
4.3.3.1 Packaging, Labellling, And Blinding Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.4 Manufacturing
4.3.4.1 Manufacturing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.5 Comparator Sourcing
4.3.5.1 Comparator Sourcing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.6 Other Services (Solutions, Ancillary Supply)
4.3.6.1 Other Services (Solutions, Ancillary Supply) Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 5 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY PHASE, 2018 - 2030 (USD MILLION)
5.1 Definitions And Scope
5.2 Clinical Trial Supply & Logistics Market By Phase: Segment Dashboard
5.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
5.4 Clinical Trial Supply & Logistics Market By Phase
5.4.1 Phase I
5.4.1.1 Phase I Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.2 Phase Ii
5.4.2.1 Phase Ii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.3 Phase Iii
5.4.3.1 Phase Iii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.4 Phase Iv
5.4.4.1 Phase Iv Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 6 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
6.1 Definitions And Scope
6.2 Clinical Trial Supply & Logistics Market By End - User: Segment Dashboard
6.3 Clinical Trial Supply & Logistics: End-User Market Share Analysis, 2022 & 2030
6.4 Clinical Trial Supply & Logistics Market By End - User
6.4.1 Pharmaceutical
6.4.1.1 Pharmaceutical Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.2 Biologicals
6.4.2.1 Biologicals Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.3 Medical Devices
6.4.3.1 Medical Device Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 7 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY THERAPEUTIC AREAS, 2018 - 2030 (USD MILLION)
7.1 Definitions And Scope
7.2 Clinical Trial Supply & Logistics Market By Therapeutic Areas: Segment Dashboard
7.3 Clinical Trial Supply & Logistics: Therapeutic Areas Market Share Analysis, 2022 & 2030
7.4 Clinical Trial Supply & Logistics Market By Therapeutic Areas
7.4.1 Oncology
7.4.1.1 Oncology Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.2 Central Nervous System (Cns) Disorders
7.4.2.1 Cns Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.3 Cardiovascular Diseases
7.4.3.1 Cardiovascular Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.4 Respiratory Diseases
7.4.4.1 Respiratory Diseases Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.5 Others
7.4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 8 CLINICAL TRIALS SUPPLY & LOGISTICS MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS, BY SERVICE, PHASE, END - USER, & THERAPEUTIC AREA
8.1 North America
8.1.1 Swot Analysis:
8.1.1.1 North America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.2 U.S.
8.1.2.1 Key Country Dynamics
8.1.2.2 Competitive Scenario
8.1.2.3 Regulatory Framework
8.1.2.4 U.S. Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.3 Canada
8.1.3.1 Key Country Dynamics
8.1.3.2 Competitive Scenario
8.1.3.3 Regulatory Framework
8.1.3.4 Canada Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2 Europe
8.2.1 Swot Analysis:
8.2.1.1 Europe Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.2 U.K.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 Regulatory Framework
8.2.2.4 Uk Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.3 France
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Regulatory Framework
8.2.3.4 France Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.4 Germany
8.2.4.1 Key Country Dynamics
8.2.4.2 Competitive Scenario
8.2.4.3 Regulatory Framework
8.2.4.4 Germany Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.5 Italy
8.2.5.1 Key Country Dynamics
8.2.5.2 Competitive Scenario
8.2.5.3 Regulatory Framework
8.2.5.4 Italy Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.6 Spain
8.2.6.1 Key Country Dynamics
8.2.6.2 Competitive Scenario
8.2.6.3 Regulatory Framework
8.2.6.4 Spain Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3 Asia Pacific
8.3.1 Swot Analysis:
8.3.1.1 Asia Pacific Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.1 India
8.3.1.1 Key Country Dynamics
8.3.1.2 Competitive Scenario
8.3.1.1 Regulatory Framework
8.3.1.2 India Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 Japan
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.1 Regulatory Framework
8.3.2.2 Japan Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 China
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.1 Regulatory Framework
8.3.3.2 China Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4 Australia
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Regulatory Framework
8.3.4.4 Australia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5 South Korea
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Regulatory Framework
8.3.5.4 South Korea Vessel Sealing Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4 Latin America
8.4.1 Swot Analysis:
8.4.1.1 Latin America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 Brazil
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Framework
8.4.2.4 Brazil Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 Mexico
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Mexico Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 Argentina
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Regulatory Framework
8.4.4.4 Argentina Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Colombia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Regulatory Framework
8.4.5.4 Colombia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Chile
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Regulatory Framework
8.4.6.4 Chile Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5 Mea
8.5.1 Swot Analysis:
8.5.1.1 Mea Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 South Africa
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Regulatory Framework
8.5.2.4 South Africa Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Saudi Arabia
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 Saudi Arabia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 UAE
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 Uae Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5 Iran
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Iran Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6 Israel
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 Regulatory Framework
8.5.6.4 Israel Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Company Market Share
9.1.1 Company market share analysis (2022)
CHAPTER 10 COMPETITIVE LANDSCAPE
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Strategy Initiatives
10.3.1 Acquisition
10.3.2 Collaboration/ Partnerships
10.3.3 Expansion
10.3.4 Product Launch
10.3.5 Others
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Phase
1.1.3 End-User
1.1.4 Therapeutic Use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
CHAPTER 3 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Technological advancements in supply chain
3.1.1.2 Increasing R&D investment by pharmaceutical and biopharmaceutical firms
3.1.1.3 Expansion of clinical trial sites
3.1.2 Market Restraint Analysis
3.1.2.1 Stringent regulation pertaining to logistics
3.1.2.2 Counterfeiting of drugs
3.1.3 SWOT Analysis by PESTEL
3.1.4 Industry Analysis - Porter’s
3.1.5 Clinical Trial Supply & Logistics Market: Impact of COVID -
3.1.5.1 IMPACT OF COVID -
3.1.5.2 SUPPLY CHAIN
3.1.5.3 CHANGING MARKET TRENDS
CHAPTER 4 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY SERVICE, 2018 - 2030 (USD MILLION)
4.1 Definitions and Scope
4.2 Clinical Trial Supply & Logistics Market by Service: Segment Dashboard
4.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
4.3.1 logistics & Distribution
4.3.1.1 Logistics & Distribution Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.2 Storage & Retention
4.3.2.1 Storage & Retention Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.3 Packaging, Labeling, And Blinding
4.3.3.1 Packaging, Labellling, And Blinding Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.4 Manufacturing
4.3.4.1 Manufacturing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.5 Comparator Sourcing
4.3.5.1 Comparator Sourcing Market Estimates And Forecast, 2018 - 2030 (In Million)
4.3.6 Other Services (Solutions, Ancillary Supply)
4.3.6.1 Other Services (Solutions, Ancillary Supply) Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 5 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY PHASE, 2018 - 2030 (USD MILLION)
5.1 Definitions And Scope
5.2 Clinical Trial Supply & Logistics Market By Phase: Segment Dashboard
5.3 Clinical Trial Supply & Logistics: Market Share Analysis, 2022 & 2030
5.4 Clinical Trial Supply & Logistics Market By Phase
5.4.1 Phase I
5.4.1.1 Phase I Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.2 Phase Ii
5.4.2.1 Phase Ii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.3 Phase Iii
5.4.3.1 Phase Iii Market Estimates And Forecast, 2018 - 2030 (In Million)
5.4.4 Phase Iv
5.4.4.1 Phase Iv Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 6 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
6.1 Definitions And Scope
6.2 Clinical Trial Supply & Logistics Market By End - User: Segment Dashboard
6.3 Clinical Trial Supply & Logistics: End-User Market Share Analysis, 2022 & 2030
6.4 Clinical Trial Supply & Logistics Market By End - User
6.4.1 Pharmaceutical
6.4.1.1 Pharmaceutical Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.2 Biologicals
6.4.2.1 Biologicals Market Estimates And Forecast, 2018 - 2030 (In Million)
6.4.3 Medical Devices
6.4.3.1 Medical Device Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 7 CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: SEGMENT ANALYSIS, BY THERAPEUTIC AREAS, 2018 - 2030 (USD MILLION)
7.1 Definitions And Scope
7.2 Clinical Trial Supply & Logistics Market By Therapeutic Areas: Segment Dashboard
7.3 Clinical Trial Supply & Logistics: Therapeutic Areas Market Share Analysis, 2022 & 2030
7.4 Clinical Trial Supply & Logistics Market By Therapeutic Areas
7.4.1 Oncology
7.4.1.1 Oncology Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.2 Central Nervous System (Cns) Disorders
7.4.2.1 Cns Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.3 Cardiovascular Diseases
7.4.3.1 Cardiovascular Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.4 Respiratory Diseases
7.4.4.1 Respiratory Diseases Market Estimates And Forecast, 2018 - 2030 (In Million)
7.4.5 Others
7.4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (In Million)
CHAPTER 8 CLINICAL TRIALS SUPPLY & LOGISTICS MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS, BY SERVICE, PHASE, END - USER, & THERAPEUTIC AREA
8.1 North America
8.1.1 Swot Analysis:
8.1.1.1 North America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.2 U.S.
8.1.2.1 Key Country Dynamics
8.1.2.2 Competitive Scenario
8.1.2.3 Regulatory Framework
8.1.2.4 U.S. Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.1.3 Canada
8.1.3.1 Key Country Dynamics
8.1.3.2 Competitive Scenario
8.1.3.3 Regulatory Framework
8.1.3.4 Canada Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2 Europe
8.2.1 Swot Analysis:
8.2.1.1 Europe Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.2 U.K.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 Regulatory Framework
8.2.2.4 Uk Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.3 France
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Regulatory Framework
8.2.3.4 France Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.4 Germany
8.2.4.1 Key Country Dynamics
8.2.4.2 Competitive Scenario
8.2.4.3 Regulatory Framework
8.2.4.4 Germany Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.5 Italy
8.2.5.1 Key Country Dynamics
8.2.5.2 Competitive Scenario
8.2.5.3 Regulatory Framework
8.2.5.4 Italy Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.2.6 Spain
8.2.6.1 Key Country Dynamics
8.2.6.2 Competitive Scenario
8.2.6.3 Regulatory Framework
8.2.6.4 Spain Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3 Asia Pacific
8.3.1 Swot Analysis:
8.3.1.1 Asia Pacific Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.1 India
8.3.1.1 Key Country Dynamics
8.3.1.2 Competitive Scenario
8.3.1.1 Regulatory Framework
8.3.1.2 India Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.2 Japan
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.1 Regulatory Framework
8.3.2.2 Japan Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.3 China
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.1 Regulatory Framework
8.3.3.2 China Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.4 Australia
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Regulatory Framework
8.3.4.4 Australia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.3.5 South Korea
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Regulatory Framework
8.3.5.4 South Korea Vessel Sealing Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4 Latin America
8.4.1 Swot Analysis:
8.4.1.1 Latin America Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2 Brazil
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Framework
8.4.2.4 Brazil Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3 Mexico
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Mexico Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4 Argentina
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Regulatory Framework
8.4.4.4 Argentina Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.5 Colombia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Regulatory Framework
8.4.5.4 Colombia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.6 Chile
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Regulatory Framework
8.4.6.4 Chile Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5 Mea
8.5.1 Swot Analysis:
8.5.1.1 Mea Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2 South Africa
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Regulatory Framework
8.5.2.4 South Africa Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3 Saudi Arabia
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 Saudi Arabia Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4 UAE
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 Uae Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5 Iran
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Iran Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6 Israel
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 Regulatory Framework
8.5.6.4 Israel Clinical Trials Supply & Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Company Market Share
9.1.1 Company market share analysis (2022)
CHAPTER 10 COMPETITIVE LANDSCAPE
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Strategy Initiatives
10.3.1 Acquisition
10.3.2 Collaboration/ Partnerships
10.3.3 Expansion
10.3.4 Product Launch
10.3.5 Others
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Secondary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Clinical trial supply & logistics market snapshot (2022)
Fig. 8 Clinical trial supply & logistics market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Porter’s five forces analysis
Fig. 13 PESTEL analysis
Fig. 14 Clinical trial supply & logistics market service outlook: Segment dashboard
Fig. 15 Clinical trial supply & logistics market: service movement analysis
Fig. 16 Logistics & distribution market, 2018 - 2030 (USD Million)
Fig. 17 Storage & retention market, 2018 - 2030 (USD Million)
Fig. 18 Packaging, labeling, and blinding market, 2018 - 2030 (USD Million)
Fig. 19 Manufacturing market, 2018 - 2030 (USD Million)
Fig. 20 Comparator sourcing market, 2018 - 2030 (USD Million)
Fig. 21 Other Services market, 2018 - 2030 (USD Million)
Fig. 22 Clinical Trial Supply & Logistics market phase outlook: Segment dashboard
Fig. 23 Clinical Trial Supply & Logistics market: Phase movement analysis
Fig. 24 Phase I based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 25 Phase II based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 26 Phase III based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 27 Phase IV based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 28 Clinical Trial Supply & Logistics market end-user outlook: Segment dashboard
Fig. 29 Clinical Trial Supply & Logistics market: End-user movement analysis
Fig. 30 Pharmaceuticals based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 31 Biologicals based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 32 Medical Device based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 33 Clinical Trial Supply & Logistics market therapeutic area outlook: Segment dashboard
Fig. 34 Clinical Trial Supply & Logistics market: Therapeutic area movement analysis
Fig. 35 Oncology based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 36 Cardiovascular based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 37 Respiratory disease based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 38 CNS & Mental Disorders based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 39 Others based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 40 Regional market: Key takeaways
Fig. 41 Regional outlook, 2022 & 2030
Fig. 42 North America market, 2018 - 2030 (USD Million)
Fig. 43 U.S. market, 2018 - 2030 (USD Million)
Fig. 44 Canada market, 2018 - 2030 (USD Million)
Fig. 45 Europe market, 2018 - 2030 (USD Million)
Fig. 46 U.K. market, 2018 - 2030 (USD Million)
Fig. 47 Germany market, 2018 - 2030 (USD Million)
Fig. 48 France market, 2018 - 2030 (USD Million)
Fig. 49 Italy market, 2018 - 2030 (USD Million)
Fig. 50 Spain market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 52 Japan market, 2018 - 2030 (USD Million)
Fig. 53 China market, 2018 - 2030 (USD Million)
Fig. 54 India market, 2018 - 2030 (USD Million)
Fig. 55 Australia market, 2018 - 2030 (USD Million)
Fig. 56 South Korea market, 2018 - 2030 (USD Million)
Fig. 57 Latin America market, 2018 - 2030 (USD Million)
Fig. 58 Brazil market, 2018 - 2030 (USD Million)
Fig. 59 Mexico market, 2018 - 2030 (USD Million)
Fig. 60 Argentina market, 2018 - 2030 (USD Million)
Fig. 61 Colombia market, 2018 - 2030 (USD Million)
Fig. 62 Chile market, 2018 - 2030 (USD Million)
Fig. 63 MEA market, 2018 - 2030 (USD Million)
Fig. 64 South Africa market, 2018 - 2030 (USD Million
Fig. 65 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 66 UAE market, 2018 - 2030 (USD Million)
Fig. 67 Israel market, 2018 - 2030 (USD Million)
Fig. 68 Iran market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Secondary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Clinical trial supply & logistics market snapshot (2022)
Fig. 8 Clinical trial supply & logistics market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Porter’s five forces analysis
Fig. 13 PESTEL analysis
Fig. 14 Clinical trial supply & logistics market service outlook: Segment dashboard
Fig. 15 Clinical trial supply & logistics market: service movement analysis
Fig. 16 Logistics & distribution market, 2018 - 2030 (USD Million)
Fig. 17 Storage & retention market, 2018 - 2030 (USD Million)
Fig. 18 Packaging, labeling, and blinding market, 2018 - 2030 (USD Million)
Fig. 19 Manufacturing market, 2018 - 2030 (USD Million)
Fig. 20 Comparator sourcing market, 2018 - 2030 (USD Million)
Fig. 21 Other Services market, 2018 - 2030 (USD Million)
Fig. 22 Clinical Trial Supply & Logistics market phase outlook: Segment dashboard
Fig. 23 Clinical Trial Supply & Logistics market: Phase movement analysis
Fig. 24 Phase I based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 25 Phase II based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 26 Phase III based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 27 Phase IV based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 28 Clinical Trial Supply & Logistics market end-user outlook: Segment dashboard
Fig. 29 Clinical Trial Supply & Logistics market: End-user movement analysis
Fig. 30 Pharmaceuticals based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 31 Biologicals based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 32 Medical Device based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 33 Clinical Trial Supply & Logistics market therapeutic area outlook: Segment dashboard
Fig. 34 Clinical Trial Supply & Logistics market: Therapeutic area movement analysis
Fig. 35 Oncology based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 36 Cardiovascular based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 37 Respiratory disease based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 38 CNS & Mental Disorders based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 39 Others based Clinical Trial Supply & Logistics market, 2018 - 2030 (USD Million)
Fig. 40 Regional market: Key takeaways
Fig. 41 Regional outlook, 2022 & 2030
Fig. 42 North America market, 2018 - 2030 (USD Million)
Fig. 43 U.S. market, 2018 - 2030 (USD Million)
Fig. 44 Canada market, 2018 - 2030 (USD Million)
Fig. 45 Europe market, 2018 - 2030 (USD Million)
Fig. 46 U.K. market, 2018 - 2030 (USD Million)
Fig. 47 Germany market, 2018 - 2030 (USD Million)
Fig. 48 France market, 2018 - 2030 (USD Million)
Fig. 49 Italy market, 2018 - 2030 (USD Million)
Fig. 50 Spain market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 52 Japan market, 2018 - 2030 (USD Million)
Fig. 53 China market, 2018 - 2030 (USD Million)
Fig. 54 India market, 2018 - 2030 (USD Million)
Fig. 55 Australia market, 2018 - 2030 (USD Million)
Fig. 56 South Korea market, 2018 - 2030 (USD Million)
Fig. 57 Latin America market, 2018 - 2030 (USD Million)
Fig. 58 Brazil market, 2018 - 2030 (USD Million)
Fig. 59 Mexico market, 2018 - 2030 (USD Million)
Fig. 60 Argentina market, 2018 - 2030 (USD Million)
Fig. 61 Colombia market, 2018 - 2030 (USD Million)
Fig. 62 Chile market, 2018 - 2030 (USD Million)
Fig. 63 MEA market, 2018 - 2030 (USD Million)
Fig. 64 South Africa market, 2018 - 2030 (USD Million
Fig. 65 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 66 UAE market, 2018 - 2030 (USD Million)
Fig. 67 Israel market, 2018 - 2030 (USD Million)
Fig. 68 Iran market, 2018 - 2030 (USD Million)
